RELB Antilichaam - N-terminalgebied: FITC (ARP38807_P050-FITC)

V-rel reticuloendotheliosis viral oncogene homolog B

IREL, I-REL, IMD53, REL-B

5971

Q01201

NP_006500

Human, Dog, Guinea Pig

The immunogen is a synthetic peptide directed towards the N terminal region of human RELB

RELB neither associates with DNA nor with RELA/p65 or REL. It stimulates promoter activity in the presence of NFKB2/p49.

NFKB2; NFKB1; BCL3; NEK6; DNMT1; DAXX; MT1M; GSK3B; CTSL; CDK1; BUD31; UQCRFS1; MTAP; COMMD9; COMMD5; MALT1; COMMD1; COMMD8; COMMD4; COMMD10; COMMD2; UBC; RAC1; SUZ12; RELA; EZH2; DPF2; YY1; CBX3; EHMT2; NFKBIA; KPNA6; SMARCA4; SMARCE1; SMARCC2; SMARCC1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

IHC, WB

Affinity Purified

0.5 mg/ml

Dog: 100%; Guinea Pig: 86%; Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

62kDa

Bernot, A., (er) Ann. Rheum. Dis. (2008) In press

Wet Ice

579

RELB

RELB

Rabbit

Transcription factor RelB

NM_006509

LRSGPASGPSVPTGRAMPSRRVARPPAAPELGALGSPDLSSLSLAVSRST